A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Gh Research PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 30,400 shares of GHRS stock, worth $281,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,400
Previous 30,400 -0.0%
Holding current value
$281,808
Previous $354,000 42.66%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$5.34 - $11.09 $109,470 - $227,345
-20,500 Reduced 40.28%
30,400 $324,000
Q4 2023

Feb 13, 2024

BUY
$5.26 - $11.04 $34,190 - $71,760
6,500 Added 14.64%
50,900 $295,000
Q3 2023

Nov 14, 2023

BUY
$9.8 - $14.15 $185,220 - $267,435
18,900 Added 74.12%
44,400 $446,000
Q2 2023

Aug 11, 2023

BUY
$7.88 - $12.74 $115,836 - $187,278
14,700 Added 136.11%
25,500 $303,000
Q1 2023

May 12, 2023

BUY
$6.02 - $10.92 $65,015 - $117,936
10,800 New
10,800 $86,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $482M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.